Prognosis after resection of Barcelona Clinic Liver Cancer (BCLC) stage 0, A, and B hepatocellular carcinoma: a comprehensive assessment of the current BCLC classification DI Tsilimigras, F Bagante, K Sahara, D Moris, JM Hyer, L Wu, F Ratti, ... Annals of surgical oncology 26, 3693-3700, 2019 | 152 | 2019 |
Trends in the incidence, treatment and outcomes of patients with intrahepatic cholangiocarcinoma in the USA: facility type is associated with margin status, use of … L Wu, DI Tsilimigras, AZ Paredes, R Mehta, JM Hyer, K Merath, K Sahara, ... World journal of surgery 43 (7), 1777-1787, 2019 | 142 | 2019 |
Very early recurrence after liver resection for intrahepatic cholangiocarcinoma: considering alternative treatment approaches DI Tsilimigras, K Sahara, L Wu, D Moris, F Bagante, A Guglielmi, ... JAMA surgery 155 (9), 823-831, 2020 | 129 | 2020 |
Small intrahepatic cholangiocarcinoma and hepatocellular carcinoma in cirrhotic livers may share similar enhancement patterns at multiphase dynamic MR imaging B Huang, L Wu, XY Lu, F Xu, CF Liu, WF Shen, NY Jia, HY Cheng, ... Radiology 281 (1), 150-157, 2016 | 88 | 2016 |
Use of machine learning for prediction of patient risk of postoperative complications after liver, pancreatic, and colorectal surgery K Merath, JM Hyer, R Mehta, A Farooq, F Bagante, K Sahara, ... Journal of Gastrointestinal Surgery 24 (8), 1843-1851, 2020 | 85 | 2020 |
Adjuvant 131I-metuximab for hepatocellular carcinoma after liver resection: a randomised, controlled, multicentre, open-label, phase 2 trial J Li, J Xing, Y Yang, J Liu, W Wang, Y Xia, Z Yan, K Wang, D Wu, L Wu, ... The Lancet Gastroenterology & Hepatology 5 (6), 548-560, 2020 | 55 | 2020 |
Management and outcomes among patients with sarcomatoid hepatocellular carcinoma: a population‐based analysis L Wu, DI Tsilimigras, A Farooq, JM Hyer, K Merath, AZ Paredes, R Mehta, ... Cancer 125 (21), 3767-3775, 2019 | 40 | 2019 |
Hepatic arterial Iodine-131–labeled metuximab injection combined with chemoembolization for unresectable hepatocellular carcinoma: interim safety and survival data from 110 … L Wu, YF Yang, NJ Ge, SQ Shen, J Liang, Y Wang, WP Zhou, F Shen, ... Cancer biotherapy & radiopharmaceuticals 25 (6), 657-663, 2010 | 39 | 2010 |
Hepatic artery injection of 131I-labelled metuximab combined with chemoembolization for intermediate hepatocellular carcinoma: a prospective nonrandomized … L Wu, YF Yang, NJ Ge, SQ Shen, J Liang, Y Wang, WP Zhou, F Shen, ... European journal of nuclear medicine and molecular imaging 39, 1306-1315, 2012 | 38 | 2012 |
Financial toxicity risk among adult patients undergoing cancer surgery in the United States: an analysis of the National Inpatient Sample A Farooq, K Merath, JM Hyer, AZ Paredes, DI Tsilimigras, K Sahara, ... Journal of surgical oncology 120 (3), 397-406, 2019 | 35 | 2019 |
Cerebral lipiodol embolism following transcatheter arterial chemoembolization for hepatocellular carcinoma L Wu, YF Yang, J Liang, SQ Shen, NJ Ge, MC Wu World journal of gastroenterology: WJG 16 (3), 398, 2010 | 27 | 2010 |
In-hospital mortality following pancreatoduodenectomy: a comprehensive analysis K Merath, R Mehta, DI Tsilimigras, A Farooq, K Sahara, AZ Paredes, L Wu, ... Journal of Gastrointestinal Surgery 24 (5), 1119-1126, 2020 | 25 | 2020 |
Quality of care among Medicare patients undergoing pancreatic surgery: safety grade, magnet recognition, and Leapfrog minimum volume standards—which quality benchmark matters? K Merath, R Mehta, DI Tsilimigras, A Farooq, K Sahara, AZ Paredes, L Wu, ... Journal of Gastrointestinal Surgery 25 (1), 269-277, 2021 | 21 | 2021 |
Analysis of authorship in hepatopancreaticobiliary surgery: women remain underrepresented A Farooq, K Sahara, A Muneeb, K Farooq, DI Tsilimigras, K Merath, ... Journal of Gastrointestinal Surgery 24 (9), 2070-2076, 2020 | 21 | 2020 |
Potential survival benefit of radiofrequency ablation for small solitary intrahepatic cholangiocarcinoma in nonsurgically managed patients: A population‐based analysis L Wu, DI Tsilimigras, A Farooq, JM Hyer, K Merath, AZ Paredes, R Mehta, ... Journal of surgical oncology 120 (8), 1358-1364, 2019 | 21 | 2019 |
Therapeutic index of lymphadenectomy among patients with pancreatic neuroendocrine tumors: a multi‐institutional analysis L Wu, K Sahara, DI Tsilimigras, SK Maithel, GA Poultsides, FG Rocha, ... Journal of surgical oncology 120 (7), 1080-1086, 2019 | 20 | 2019 |
Machine learning predicts unpredicted deaths with high accuracy following hepatopancreatic surgery K Sahara, AZ Paredes, DI Tsilimigras, K Sasaki, A Moro, JM Hyer, ... Hepatobiliary Surgery and Nutrition 10 (1), 20, 2021 | 18 | 2021 |
Impact of liver cirrhosis on perioperative outcomes among elderly patients undergoing hepatectomy: the effect of minimally invasive surgery K Sahara, AZ Paredes, DI Tsilimigras, JM Hyer, K Merath, L Wu, R Mehta, ... Journal of Gastrointestinal Surgery 23 (12), 2346-2353, 2019 | 16 | 2019 |
Use of perioperative epidural analgesia among Medicare patients undergoing hepatic and pancreatic surgery K Merath, JM Hyer, R Mehta, F Bagante, A Paredes, L Wu, K Sahara, ... HPB 21 (8), 1064-1071, 2019 | 14 | 2019 |
Immunotherapy utilization for hepatobiliary cancer in the United States: disparities among patients with different socioeconomic status K Sahara, SA Farooq, DI Tsilimigras, K Merath, AZ Paredes, L Wu, ... Hepatobiliary Surgery and Nutrition 9 (1), 13, 2020 | 13 | 2020 |